RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Journal of molecular cell biology
View this publicationJournal of molecular cell biology
View this publicationImmunity
View this publicationClinical nuclear medicine
View this publicationFrontiers in genetics
View this publicationJournal of clinical medicine
View this publicationJournal of leukocyte biology
View this publicationJournal of CME
View this publicationEuropean journal of immunology
View this publicationFrontiers in tropical diseases
View this publicationJournal of cancer research and clinical oncology
View this publication